Skip to main content
logo
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
8.60
-0.20 (-2.27%)
At close: Jul 20, 2026, 4:00 PM EDT
8.63
+0.03 (0.35%)
Pre-market: Jul 21, 2026, 4:32 AM EDT

Xeris Biopharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,5591,305507325181366
Market Cap Growth
85.03%157.58%56.05%79.10%-50.46%24.75%
Enterprise Value
1,7051,452706.39481.35257.33351.51
Last Close Price
8.607.853.392.351.332.93
PE Ratio
134.162447.71----
Forward PE
70.6764.50----
PS Ratio
4.954.472.491.981.647.38
PB Ratio
114.0695.32-17.10-47.864.013.84
P/FCF Ratio
32.8046.72----
P/OCF Ratio
32.1245.58----
EV/Sales Ratio
5.424.973.482.942.337.09
EV/EBITDA Ratio
35.4739.18----
EV/EBIT Ratio
47.5058.32----
EV/FCF Ratio
35.8951.98----
Debt / Equity Ratio
19.3918.40-8.45-33.284.350.92
Debt / EBITDA Ratio
5.386.97----
Debt / FCF Ratio
5.449.24----
Net Debt / Equity Ratio
11.2810.74-6.75-23.111.68-0.15
Net Debt / EBITDA Ratio
3.053.97-9.26-4.95-1.090.13
Net Debt / FCF Ratio
3.095.27-5.28-3.18-0.740.15
Asset Turnover
0.810.830.630.490.340.21
Inventory Turnover
0.620.730.850.901.061.01
Quick Ratio
1.421.481.121.172.081.52
Current Ratio
2.122.191.671.642.541.80
Return on Equity (ROE)
89.95%-6.96%301.32%-324.20%-134.83%-190.28%
Return on Assets (ROA)
9.26%7.05%-10.01%-12.93%-24.88%-49.69%
Return on Invested Capital (ROIC)
22.40%12.99%-14.36%-24.75%-79.87%-339.40%
Return on Capital Employed (ROCE)
13.12%10.03%-14.95%-17.66%-33.03%-64.65%
Earnings Yield
0.77%0.04%----
FCF Yield
3.05%2.14%----
Buyback Yield / Dilution
-19.55%-17.69%-6.61%-1.51%-71.62%-85.32%
Total Shareholder Return
-19.55%-17.69%-6.61%-1.51%-71.62%-85.32%
SEC Filings: 10-K · 10-Q